Never Miss a Biotech Deal Again – Daily 5-Min Tape in Your Inbox (Free)Join 2,000+ VCs, BD pros & investors:
Jan 21, 2026
Pfizer taps Novavax's Matrix-M, PBM reform language advances, and fresh financing hits the tape despite the selloff.
Jan 20, 2026
Jan 19, 2026
Jan 16, 2026
Jan 15, 2026
Jan 14, 2026
Jan 13, 2026
Jan 12, 2026
Jan 9, 2026
Jan 8, 2026
Private financings — Company, date, round, investors, therapeutic area, and a one-line “what they do.”
Jan 18, 2026
A data-backed snapshot of 2025 pharma/biotech venture funding, plus a subscriber-only downloadable report.
Jan 11, 2026
A complete, scannable list of 2025 biopharma/biotech M&A deals >$500M (public + private) — with subsector, therapeutic area and stage.
Jan 10, 2026
The 10 biggest BioPharma M&A deals announced in 2025, with deal value, stage, and the investor-grade “why” for each.
Plain-English definitions of the biotech funding terms you see in press releases, term sheets, IPOs, and M&A.